ICD-10 Code L70.9: Acne, Unspecified – Complete Coding & Billing Guide

What Does ICD-10 Code L70.9 Mean?

ICD-10 code L70.9 designates acne, unspecified — a billable diagnosis under Chapter 12 (Diseases of the Skin and Subcutaneous Tissue) of the ICD-10-CM Official Coding Guidelines. It is used when a provider documents an acne diagnosis but does not specify the clinical subtype in the medical record.

Key attributes of L70.9:

• Valid and billable for fiscal year 2026 (effective October 1, 2025)
• Applicable in both inpatient and outpatient settings
• Classified under the L70 acne category, subcategory of L60–L75 (Disorders of Skin Appendages)
• Carries a “Not Otherwise Specified” (NOS) designation — meaning it reflects the absence of further specificity in provider documentation, not an undefined clinical condition
• Formerly mapped from ICD-9-CM 706.1 (other acne); no exact crosswalk equivalent

What Conditions and Diagnoses Does L70.9 Cover?

L70.9 is appropriate when the clinical record confirms the presence of acne but does not include enough detail to assign a more specific code within the L70 family. In practice, this code captures encounters where the provider documents “acne” without further qualification.

Clinical presentations that may fall under L70.9 when subtype is undocumented:

• Inflammatory acne lesions (papules, pustules) without formal subtype classification
• Comedonal acne (blackheads, whiteheads) noted but not further specified
• Mixed acne presentations documented only as “acne” or “acneiform eruption”
• Follow-up visits where the acne type was identified at a prior encounter but is not re-stated in current notes
• New patient presentations where initial assessment has not yet established lesion morphology in detail

What Does L70.9 Specifically Exclude?

L70.9 does not apply when documentation supports a more specific acne type. The following conditions carry their own billable codes and must not be collapsed into L70.9:

• Acne vulgaris — L70.0 (comedones, inflammatory papules/pustules)
• Acne conglobata — L70.1 (nodulocystic, abscesses, scarring)
• Acne varioliformis — L70.2 (rare acneiform eruption)
• Acne tropica — L70.3 (climate-induced)
• Infantile acne — L70.4 (neonatal or infant presentation)
• Acné excoriée — L70.5 (self-excoriated, psychogenic component)
• Other acne — L70.8 (subtypes not elsewhere classifiable)
• Rosacea — L71.x (no comedones; distinct pilosebaceous disorder)
• Perioral dermatitis — L71.0 (different etiology and distribution)

When Is L70.9 the Right Code to Use?

L70.9 is a last-resort code within the L70 family — appropriate only after a coder has confirmed that specificity is genuinely unavailable. Using L70.9 when documentation supports a more specific code is a coding error and an audit risk.

Apply L70.9 using this selection sequence:

1. Review the provider’s assessment for any qualifying language — “vulgaris,” “cystic,” “nodulocystic,” “excoriated,” “infantile,” or “tropical.”
2. Check clinical notes for lesion morphology descriptions: comedones, papules, pustules, nodules, cysts, or scarring.
3. If the provider documents specific lesion types consistent with a defined subtype, assign the corresponding specific code (e.g., L70.0 for comedonal/inflammatory vulgaris).
4. Query the provider if documentation is ambiguous but clinical detail exists that could support specificity — do not assume L70.9 by default.
5. Assign L70.9 only when none of the above steps yield a supportable specific code.

How Does L70.9 Differ From L70.0 (Acne Vulgaris)?

This is the most common point of confusion for coders. Acne vulgaris (L70.0) is the most prevalent acne subtype and shares significant overlap with what providers often document informally as “acne.”

In practice, coders frequently encounter notes that read simply “acne — continue tretinoin” with no lesion description. That scenario defaults to L70.9 unless prior documentation that established L70.0 is explicitly carried forward.

What Documentation Is Required to Support L70.9?

Because L70.9 is an unspecified code, documentation requirements are lighter than those for specific subtypes — but the absence of specificity must itself be justifiable, not simply the result of provider shorthand.

What Must the Provider Document in the Clinical Notes?

1. An explicit diagnosis or assessment of “acne” (provider attribution is required — coders cannot infer the diagnosis)
2. Affected body area(s) — face, back, chest, shoulders, or other sites
3. Notation that the acne type is uncharacterized, or absence of lesion morphology description
4. Treatment plan consistent with an acne diagnosis (topical retinoids, antibiotics, hormonal therapy, or procedural intervention)
5. Absence of findings that would support a more specific code (e.g., no notation of nodules, cysts, abscesses, or excoriation)

Which Diagnostic or Lab Results Support This Code?

Unlike many ICD-10 codes, L70.9 typically does not require laboratory confirmation. However, the following findings may appear in the record alongside this code:

• Dermatologic visual exam documenting acneiform lesions without further classification
• Hormonal labs (androgens, DHEA-S) ordered as part of workup — do not change the acne code but may support additional diagnoses
• Cultures ordered to rule out bacterial folliculitis — document clearly that culture results are pending or negative
• Photography or lesion mapping that describes distribution but not subtype

What Is the Documentation Standard for Inpatient vs. Outpatient Settings?

How Does L70.9 Affect Medical Billing and Claims?

L70.9 is a billable code, but its unspecified status introduces specific revenue cycle risks that coders and billers must proactively manage.

Key billing considerations:

• Medical necessity for procedures (e.g., acne surgery, chemical peels, light therapy) may be questioned when only L70.9 is present — payers often require lesion-type specificity to link procedure to necessity
• Commercial payers, particularly those following LCD (Local Coverage Determination) policies for dermatology procedures, may deny claims when L70.9 appears without supporting specificity
• Isotretinoin (Accutane) prior authorizations almost universally require L70.0 or L70.1 — L70.9 alone is routinely rejected
• CMS does not maintain a specific National Coverage Determination (NCD) for acne treatment, leaving coverage decisions to Medicare Administrative Contractors (MACs) and their LCDs
• According to published dermatology billing analysis, nearly 30% of isotretinoin-related claims face delays or denials tied to incomplete diagnosis documentation (JAMA Dermatology)

What CPT or Procedure Codes Are Commonly Billed With L70.9?

Are There Any Prior Authorization or Coverage Restrictions?

• Oral isotretinoin therapy requires L70.0 or L70.1 in virtually all prior authorization requests — L70.9 alone will not satisfy medical necessity criteria
• Blue Cross Blue Shield, UnitedHealthcare, and Aetna all require documentation of treatment failure before approving systemic acne therapies; the diagnosis code must align with the severity indicated
• Medicare rarely covers elective dermatology acne treatment; when covered, documentation must establish medical necessity beyond cosmetic concern
• HIPAA transaction rules require the decimal to be omitted when filing electronically (submit as L709, not L70.9)

What Coding Errors Should You Avoid With L70.9?

Auditors commonly flag L70.9 claims during coding audit preparation reviews for dermatology practices. The following errors appear most frequently:

1. Default coding to L70.9 when documentation supports L70.0 — the most common and highest-risk error; L70.0 applies to the vast majority of acne vulgaris encounters
2. Using L70.9 on isotretinoin-linked claims — will nearly always result in prior authorization failure or claim denial
3. Assigning L70.9 for rosacea or perioral dermatitis — these are distinct pilosebaceous disorders with their own L71.x codes
4. Submitting L70.9 without a corresponding E/M or procedure code — diagnosis codes do not stand alone; the claim requires a linked service
5. Applying L70.9 to acne scarring — scarring resulting from acne is coded separately (e.g., L90.5, scar conditions) and should not be rolled into the primary acne code
6. Decimal point inclusion on electronic claims — submitting “L70.9” with the period will trigger rejection at clearinghouse; submit as “L709”

What Do Auditors Look for When Reviewing Claims With L70.9?

Auditors reviewing acne claims for revenue cycle compliance typically flag:

• Documentation that describes specific lesion morphology but uses an unspecified code
• Consecutive encounters with L70.9 for the same patient where specificity should have been established by the second visit
• L70.9 paired with procedure codes that require clinical justification tied to lesion type
• Prescription history (isotretinoin, spironolactone, oral antibiotics) that implies a diagnosed specific subtype without a corresponding specific code
• Missing physical exam documentation when acne is listed as the primary diagnosis

How Does L70.9 Relate to Other ICD-10 Codes?

Understanding where L70.9 sits within the broader code landscape helps coders avoid miscoding and supports correct sequencing in multi-diagnosis encounters.

What Is the Correct Code Sequencing When L70.9 Appears With Other Diagnoses?

1. L70.9 is sequenced as the principal or first-listed diagnosis when acne is the primary reason for the encounter.
2. If the encounter addresses both acne and a complication (e.g., acne scarring, secondary infection), sequence the condition responsible for the majority of resources first.
3. When a secondary bacterial infection is present (e.g., Staphylococcus-related folliculitis), code the infection separately and use “code also” logic — L70.9 does not capture the infectious component.
4. For encounters where acne is incidental to another primary condition (e.g., a diabetic patient noted to have acne in passing), sequence the primary condition first and list L70.9 as an additional code.

Real-World Coding Scenario — How L70.9 Is Applied in Practice

Patient encounter: A 17-year-old male presents for an established-patient follow-up at a dermatology clinic. The provider’s note reads: “Patient returns for acne follow-up. Doing better on doxycycline. Continue current regimen. RTC in 3 months.” No skin exam findings are documented. No lesion morphology, distribution, or severity grade is recorded.

Correct Code Application

• L70.9 — Acne, unspecified
• 99213-25 — Office visit, established patient, with modifier 25 if a separate procedure is performed
• Rationale: The provider’s note confirms acne as the diagnosis and the purpose of the encounter, but no lesion type documentation allows assignment of L70.0 or any other specific code. L70.9 accurately reflects what is documented.

Common Mistake in This Scenario

• Incorrect code assigned: L70.0 — Acne vulgaris
• Why it fails: L70.0 requires documentation of comedones, papules, or pustules consistent with acne vulgaris. Assigning L70.0 based on a presumed or typical clinical presentation — without supporting documentation — constitutes diagnosis code specificity overcoding, which is an audit risk under OIG guidelines.
• Correct action: The coder should either query the provider for documentation of lesion findings or assign L70.9 as the most accurate code given what is documented.

Frequently Asked Questions About ICD-10 Code L70.9

Is ICD-10 Code L70.9 Still Valid for Use in 2026?

ICD-10 code L70.9 remains a valid, billable diagnosis code for fiscal year 2026, effective October 1, 2025, with no changes to its description or validity status. Coders should verify annually against the ICD-10-CM Official Coding Guidelines released by CMS to confirm no updates have been applied to the L70 category.

What Is the Difference Between L70.9 and L70.0?

L70.9 is assigned when documentation confirms acne without specifying the subtype, while L70.0 (acne vulgaris) requires documented clinical findings such as comedones, papules, or pustules. In practice, L70.0 should be used far more frequently than L70.9 — if the provider’s notes describe any lesion morphology typical of common acne, L70.0 is the more accurate and defensible choice.

Can L70.9 Be Used for Cystic Acne?

No — cystic or nodulocystic acne presentations should be coded to L70.0 (acne vulgaris, which includes cystic presentations) or L70.1 (acne conglobata) if the documentation supports severe nodular-cystic disease with abscesses or scarring. Assigning L70.9 for a documented cystic acne presentation would constitute undercoding and could compromise medical necessity justification for systemic treatments.

Will L70.9 Cause a Claim Denial?

L70.9 can trigger claim denials in specific circumstances, particularly when it is linked to isotretinoin prior authorizations, acne surgery procedures, or systemic antibiotic therapy where payers require a more specific diagnosis to establish medical necessity. Claims for routine evaluation and management services are less likely to be denied on the basis of L70.9 alone, provided the clinical documentation is otherwise complete.

Should I Query the Provider Before Using L70.9?

Yes — if the clinical notes contain any language suggesting lesion type, severity, or distribution that could support a more specific L70.x code, a compliant provider query is appropriate before defaulting to L70.9. However, coders must not assign a more specific code than the documentation supports; if the provider does not respond or cannot add specificity, L70.9 is the correct default.

Does L70.9 Require a Separate Code for Acne Scarring?

Yes. Acne scarring is not included in L70.9 and must be coded separately when it is evaluated or treated. Relevant codes include L90.5 (scar and fibrosis of skin) or L91.0 (hypertrophic scar/keloid), depending on the documented scarring type. Both the acne code and the scar code should appear on the claim when both conditions are addressed in the same encounter.

Key Takeaways

Every coder billing dermatology encounters should keep these points in mind when working with L70.9:

• L70.9 is a valid but limited code — it should never be used as a default when documentation supports a more specific L70.x assignment
• L70.0 (acne vulgaris) covers the vast majority of acne encounters; review clinical notes for lesion morphology before defaulting to L70.9
• Isotretinoin and other systemic acne treatments almost always require a specific code for prior authorization and medical necessity purposes
• Omit the decimal point when submitting L70.9 electronically — file as “L709” to avoid clearinghouse rejections
• Provider queries are appropriate and recommended when clinical detail could support a more specific code
• Acne scarring requires a separate, additional diagnosis code — it is not bundled into L70.9
• Consecutive use of L70.9 for the same patient across multiple encounters without ever establishing specificity is a pattern that draws audit scrutiny

For comprehensive guidance on dermatology coding, consult the CMS ICD-10-CM code lookup and tabular instructions and the AHA Coding Clinic for ICD-10-CM for official guidance on code application. Additional acne coding resources are available through AAPC’s dermatology coding library and the WHO ICD-10 reference browser.